Colfax Corporation
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Matthew Trerotola
- Full Time Employees
- 16,200
- Sector
- Industrials
- Industry
- Industrial - Machinery
- Address
- 420 National Business Pkwy Fl 5 Annapolis Junction MD United States of America 19808
- IPO Date
- May 8, 2008
- CIK
- 0001420800
- Website
- colfaxcorp.com
- Similar Companies
- Business
- Colfax Corporation (NYSE: CFX), now operating as Enovis Corporation following a 2022 rebranding and spin-off of its ESAB industrial welding business, is a medical technology company that develops, manufactures and distributes clinically differentiated orthopedic solutions and recovery products to improve patient outcomes across the care continuum from injury prevention to rehabilitation and reconstructive surgery; its core offerings span the Prevention & Recovery segment, including rigid and soft orthopedic bracing, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators for pain management, physical therapy devices, and DVT prevention products; and the Reconstructive segment, featuring surgical implants and productivity tools for hip, knee, shoulder, elbow, foot, ankle and finger joints, marketed under brands such as DonJoy, Aircast, Exos, Procare, Fast Freeze, Regeneration and Enovis Surgical. Enovis serves healthcare professionals, patients with musculoskeletal conditions from degenerative diseases, trauma, sports injuries or surgery, and operates globally with over 5,000 employees across six continents and manufacturing sites in more than 12 locations, including facilities in the US, Europe and Asia. Founded in 1995 by brothers Steven and Mitchell Rales and originally headquartered in Richmond, Virginia before relocating to Annapolis Junction, Maryland, the company has executed a strategic transformation from industrial fluid handling and fabrication technologies to a pure-play medical device focus, highlighted by the 2017 divestiture of its fluid handling business to Circor International for $860 million, the 2018 sale of Howden Turbo to KPS Capital Partners for $1.8 billion, the 2019 acquisition of DJO Global for $3.15 billion to enter orthopedics, the 2022 ESAB spin-off, the 2023 agreement and January 2024 completion of the €800 million ($880 million) acquisition of LimaCorporate to bolster extremity implants and expand in Europe, and seven smaller bolt-on deals in 2024 totaling $35 million alongside ongoing Lima integration.
Company News
Shentel and Glo Fiber Honored with 2026 CFX Top Ops Award for Community Relations
New Flyer awarded Buy America-compliant order from Denver RTD supporting U.S. manufacturing and East Colfax BRT
Canfor Pulp Products Inc. (CFX:CA) Shareholder/Analyst Call Prepared Remarks Transcript
Canfor Pulp Products (TSE:CFX) Stock Passes Above Two Hundred Day Moving Average – Here’s What Happened
Natural Grocers® Announces the Closure of Downtown Denver Store at Colfax and Washington
Enovis (NYSE:ENOV) vs. Envoy Medical (NASDAQ:COCH) Financial Survey
ESAB Set to Join S&P MidCap 400; PROG Holdings to Join S&P SmallCap 600
KeyBanc, Morgan Stanley Slash Price Target On Colfax
Colfax (CFX) Q4 Earnings & Revenues Surpass Estimates, Up Y/Y
Colfax Corporation (CFX) CEO Matt Trerotola on Q4 2021 Results - Earnings Call Transcript
Colfax (CFX) Beats Q4 Earnings and Revenue Estimates
Colfax (CFX) Exhibits Strong Prospects, Headwinds Persist
Colfax Schedules Fourth Quarter and Fiscal Year 2021 Earnings Release and Conference Call
Colfax's (CFX) Product Strength Aids Amid Cost & Supply Woes
Colfax to Present at the 40th Annual JP Morgan Healthcare Conference
Forget The Covid Apocalypse, Focus On Stocks That Closed Green After Friday's Monster Sell Off
Colfax Corporation's (CFX) CEO Matt Trerotola on Q3 2021 Results - Earnings Call Transcript
Colfax (CFX) Meets Earnings Estimates in Q3, Lowers View
Colfax (CFX) Q3 Earnings Match Estimates
Colfax Clocks 20% Sales Growth In Q3, Beats Estimates